Loading...

IGF-1 and Anti-VEGF in ROP: Has the time come?

Treatment of ROP is currently evolving. Novel therapeutic options are emerging that have the potential to complement existing therapies and improve treatment outcomes. However, any new therapeutic options must be thoroughly evaluated before existing (and successful) treatment paradigms can be amende...

Full description

Saved in:
Bibliographic Details
Main Authors: Stahl, Andreas, Hellstrom, Ann, Smith, Lois E.H.
Format: Artigo
Language:Inglês
Published: 2014
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4197141/
https://ncbi.nlm.nih.gov/pubmed/25300950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000365132
Tags: Add Tag
No Tags, Be the first to tag this record!